Founded Year

2013

Stage

IPO | IPO

Date of IPO

1/2/2013

Market Cap

410.55B

Stock Price

232.36

Revenue

$0000 

About AbbVie

AbbVie operates as a biopharmaceutical company focused on developing medicines in the healthcare sector. The company works on therapeutics for various health issues, including immunology, oncology, neuroscience, eye care, and aesthetics. It was founded in 2013 and is based in North Chicago, Illinois.

Headquarters Location

1 North Waukegan Road Department 036M, Building J23-3

North Chicago, Illinois, 60064,

United States

800-240-1043

Loading...

Loading...

Research containing AbbVie

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned AbbVie in 2 CB Insights research briefs, most recently on Jul 3, 2025.

Expert Collections containing AbbVie

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

AbbVie is included in 1 Expert Collection, including Fortune 500 Investor list.

F

Fortune 500 Investor list

590 items

This is a collection of investors named in the 2019 Fortune 500 list of companies. All CB Insights profiles for active investment arms of a Fortune 500 company are included.

AbbVie Patents

AbbVie has filed 1725 patents.

The 3 most popular patent topics include:

  • clusters of differentiation
  • monoclonal antibodies
  • transcription factors
patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/15/2019

3/18/2025

Monoamine oxidase inhibitors, Prodrugs, Abandoned drugs, Phenols, Beta blockers

Grant

Application Date

11/15/2019

Grant Date

3/18/2025

Title

Related Topics

Monoamine oxidase inhibitors, Prodrugs, Abandoned drugs, Phenols, Beta blockers

Status

Grant

Latest AbbVie News

According to DelveInsight, the Medical Aesthetic Devices Market is projected to grow at a CAGR of 11.46% through 2030

Nov 14, 2025

In the expanding aesthetic devices market, this question holds significant importance as clinics strive to balance efficiency with patient satisfaction. This robust growth is primarily driven by the increasing aging population and the rising popularity of aesthetic procedures. Additionally, greater awareness of physical appearance, the expanding range of cosmetic treatment options, and a global shift toward minimally invasive and non-invasive procedures are further propelling market expansion. Other contributing factors include the growing prevalence of obesity and ongoing technological innovations in aesthetic devices. DelveInsight's Medical Aesthetic Devices Market Insights report offers comprehensive analyses of current and projected market trends, key drivers and barriers, competitive landscape, and market share insights of leading companies operating in this space. Request for a sample page report @ https://www.delveinsight.com/report-store/medical-aesthetic-devices-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr Key Takeaways from the Medical Aesthetic Devices Market Report The Medical Aesthetic Devices market is expected to register a moderate CAGR between 2024 and 2030. According to DelveInsight's estimates, North America is projected to remain the leading regional market throughout the forecast period. Several key players are actively shaping the market landscape, including Johnson & Johnson, HansBioMed, AbbVie Inc., Sebbin, Sientra Inc., POLYTECH Health & Aesthetics GmbH, Suneva Medical, Hanson Medical Inc., SurgiSil, Surgiform Technologies LLC, Alma Lasers, Candela Medical, Lumenis, Cutera, Sciton Inc., Merz Pharma GmbH & Co. KGaA, Bausch Health Companies Inc., Venus Concept, TRIA Beauty, Cynosure Inc., and Galderma, among others. Recent industry developments highlight ongoing innovation: In May 2021, GC Aesthetics, Inc. launched PERLE™, a next-generation breast implant line. In February 2021, Galderma secured U.S. FDA approval for Restylane Defyne, designed for the augmentation and correction of mild to moderate chin retrusion in adults aged 21 and above. In November 2020, Lutronic introduced IntelliSTIM, a third-generation body sculpting system featuring advanced intelligent muscle stimulation technology. To read more about the latest highlights related to the Medical Aesthetic Devices market, get a snapshot of the key highlights entailed in the Global Medical Aesthetic Devices Market Report Medical Aesthetic Devices Overview Medical aesthetic devices refer to advanced tools and technologies developed to enhance physical appearance through surgical, minimally invasive, or non-invasive procedures. These devices are extensively utilized for body contouring, skin tightening, facial rejuvenation, and hair removal, as well as for addressing age-related changes, obesity-related concerns, and other aesthetic conditions that impact one's appearance. Medical Aesthetic Devices Market Insights North America is anticipated to hold a substantial share of the global medical aesthetic devices market in 2023 and is expected to retain its leading position throughout the forecast period. This strong regional presence is primarily driven by the increasing number of cosmetic surgeries, the rising prevalence of obesity, trauma cases, and breast cancer, along with the availability of advanced healthcare infrastructure and the concentration of key market players in the region. According to the American Society of Plastic Surgeons (2020), approximately 15.6 million cosmetic procedures were performed in the U.S., comprising 2.3 million surgical and 13.2 million minimally invasive procedures. Likewise, data from the International Society of Aesthetic Plastic Surgery (2020) revealed that Mexico conducted about 404,229 non-surgical aesthetic procedures, with botulinum toxin treatments representing 48% of all minimally invasive interventions. Together, these trends underscore the strong and sustained demand for medical aesthetic devices across North America, further solidifying its dominant market position. To know more about why North America is leading the market growth in the Medical Aesthetic Devices market, get a snapshot of the Medical Aesthetic Devices Market Outlook Medical Aesthetic Devices Market Dynamics The medical aesthetic devices market is poised for substantial growth, largely fueled by the increasing number of cosmetic procedures conducted worldwide. As reported by the International Society of Aesthetic Plastic Surgery (2021), the number of cosmetic surgeries globally rose from 10,129,528 in 2020 to 12,840,688 in 2021. In that year, the most common procedures included 477,705 facelifts, 290,844 neck lifts, 290,107 brow lifts, 113,206 thigh lifts, 140,158 upper arm lifts, 96,312 lower body lifts, and 63,190 buttock lifts. Additionally, there were 1,903,063 liposuctions, 1,685,471 breast augmentations, 1,446,890 eyelid surgeries, 995,149 rhinoplasties, and 991,361 abdominoplasties performed globally. By comparison, 2020 recorded approximately 3.9 million face and neck procedures, 3.1 million breast surgeries, and 3.15 million body and extremity procedures worldwide. This upward trend underscores the growing global demand for aesthetic interventions, which is expected to drive the expansion of the medical aesthetic devices market from 2023 to 2030. Moreover, the aging global population is anticipated to further boost market growth. Age-related concerns—such as facial sagging, wrinkles, and skin texture deterioration—are prompting more older adults to pursue aesthetic treatments. Additionally, increasing acceptance of cosmetic procedures among individuals aged 50 and above is expected to amplify market demand in the coming years. Medical Aesthetic Devices Market Drivers: Increase in the number of aesthetically conscious population across the globe Growing preference for minimally invasive and non-invasive aesthetic procedures Get a sneak peek at the Medical Aesthetic Devices market dynamics Scope of the Medical Aesthetic Devices Market Report: Coverage: Global Study Period: 2022 to 2030 Key Medical Aesthetic Devices Companies: Johnson & Johnson, HansBioMed., AbbVie Inc., Sebbin, Sientra, Inc., POLYTECH Health & Aesthetics GmbH, Suneva Medical, Hanson Medical Inc., SurgiSil, Surgiform Technologies LLC, Alma Lasers, Candela Medical., Lumenis., Cutera., Sciton Inc, Merz Pharma GmbH & Co.KGaA, Bausch Health Companies Inc., Venus Concept., TRIA BEAUTY, Cynosure Inc., GALDERMA, and others. Which MedTech key players in the Medical Aesthetic Devices market are set to emerge as the trendsetter, explore @ Medical Aesthetic Devices Companies About DelveInsight DelveInsight is a premier healthcare business consultant and market research firm, specializing in life sciences. We empower pharmaceutical companies with comprehensive end-to-end solutions designed to enhance performance and drive growth. Our expert healthcare consulting services offer in-depth market analysis, helping businesses accelerate growth and navigate challenges with actionable, results-driven strategies. Media Contact Company Name: DelveInsight Business Research LLP Contact Person: Kritika Rehani Email: Send Email Phone: Address: 304 S. Jones Blvd #2432 City: Las Vegas State: Nevada Country: United States Website: https://www.delveinsight.com/

AbbVie Frequently Asked Questions (FAQ)

  • When was AbbVie founded?

    AbbVie was founded in 2013.

  • Where is AbbVie's headquarters?

    AbbVie's headquarters is located at 1 North Waukegan Road, North Chicago.

  • What is AbbVie's latest funding round?

    AbbVie's latest funding round is IPO.

  • Who are the investors of AbbVie?

    Investors of AbbVie include Abbott and AME Cloud Ventures.

  • Who are AbbVie's competitors?

    Competitors of AbbVie include Seagen, Viatris, Moderna, Novartis, Genentech and 7 more.

Loading...

Compare AbbVie to Competitors

Novartis Logo
Novartis

Novartis develops and offers a range of medicines aimed at treating serious diseases, providing support for patients and healthcare professionals, and conducting research to discover new therapies. The company also focuses on environmental sustainability and ethical practices in the pharmaceutical industry. It was founded in 1996 and is based in Basel, Switzerland.

Servier Logo
Servier

Servier operates as a pharmaceutical company, engages in the research, development, and production of medications for various diseases, including targeted therapies for cancer, cardiovascular treatments, diabetes, and drugs for immuno-inflammatory and neuropsychiatric conditions. The company also produces generic drugs. It was founded in 1954 and is based in Suresnes, France.

B
Boehringer Ingelheim

Boehringer Ingelheim operates within the pharmaceutical and animal health sectors. The company conducts research and development of products for humans and animals. Boehringer Ingelheim serves the healthcare industry with an emphasis on pharmaceutical products. It was founded in 1885 and is based in Ingelheim am Rhein, Germany.

Bristol-Myers Squibb Logo
Bristol-Myers Squibb

Bristol-Myers Squibb operates as a biopharmaceutical company involved in the discovery, development, and delivery of medicines across various therapeutic areas. The company specializes in treatments for oncology, hematology, immunology, cardiovascular disease, and fibrosis, utilizing translational medicine and data analytics. Bristol-Myers Squibb also engages in health equity initiatives through its foundation to improve health outcomes for populations affected by serious diseases. It was founded in 1887 and is based in Princeton, New Jersey.

T
Teva México

Teva México specializes in the pharmaceutical industry, focusing on the development and manufacturing of generic medications. The company offers a range of generic medicines designed to improve health outcomes for patients. Teva México primarily serves the healthcare sector by providing medication options. It is based in Ciudad de México, Mexico.

P
Pfizer

Pfizer is a biopharmaceutical company involved in the discovery, development, and manufacturing of medications and vaccines aimed at improving health outcomes. The company serves the healthcare sector with its medical solutions. It is based in Jakarta, Indonesia.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.